Health committee  I think just coming from the perspective of surveillance, we already have some of that in Canada. I talked a little bit about the Canadian nosocomial infection surveillance program. They develop standardized case definitions that are used in a small pocket of tertiary care facili

Health committee  From my perspective, yes, I think there is. I would defer to my clinician colleagues on looking at that. I think there is opportunity in looking at antimicrobial-resistant trending across the country and also globally so that you can see what's happening in other areas and ther

Health committee  I don't actually know the amount, but I do know there are pre-existing platforms in infrastructure that we can build upon and leverage so that we're not going out and spending $25 million on a database or a national repository. We can pull and leverage what's already pre-existing

Health committee  I think it's important to have one central repository, with everyone collecting data using the same methodology and the same case definitions. You'll find different epidemiological patterns based on where you are in the country. We know, for example, in the west there were higher

Health committee  I think your question is a good one. We have a number of surveillance systems in place. I think there's an opportunity for Canada to use what already exists. There's good infrastructure that can be scalable and integrated, so that we are comparing the same thing across the board.

Health committee  Research and innovation.

Health committee  Recently, IPAC Canada has partnered with a number of other national organizations, such as the Public Health Agency of Canada, the Canadian Institute for Health Information, and CPSI, which is the Canadian Patient Safety Institute. We started out with one day of information shari

Health committee  Thank you, Mr. Chair. Good afternoon, everyone. My name is Suzanne Rhodenizer Rose, and I serve as past president of Infection Prevention and Control Canada. I am very pleased to be with you this afternoon to address the pressing issue of antimicrobial resistance, or AMR, in Ca